S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Critical asset just had biggest fall on record (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Critical asset just had biggest fall on record (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Critical asset just had biggest fall on record (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Critical asset just had biggest fall on record (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
What to watch for as China's major political meeting of the year gets underway
NASDAQ:CTHR

Charles & Colvard, Ltd. (CTHR) Stock Price, News & Analysis

$0.35
-0.01 (-2.76%)
(As of 03/1/2024 ET)
Today's Range
$0.34
$0.38
50-Day Range
$0.32
$0.47
52-Week Range
$0.29
$1.26
Volume
205,576 shs
Average Volume
180,311 shs
Market Capitalization
$10.68 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Charles & Colvard, Ltd. MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.17% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.76mentions of Charles & Colvard, Ltd. in the last 14 days
Based on 6 Articles This Week
Insider Trading
Acquiring Shares
$65,975 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.91 out of 5 stars

Consumer Discretionary Sector

209th out of 269 stocks

Jewelry, Silverware, & Plated Ware Industry

2nd out of 2 stocks


CTHR stock logo

About Charles & Colvard, Ltd. Stock (NASDAQ:CTHR)

Charles & Colvard, Ltd. operates as a fine jewelry company in the United States and internationally. The company operates in two segments, Online Channels and Traditional. It manufactures, markets, and distributes moissanite jewels and finished moissanite jewelry under the Charles & Colvard Created Moissanite brand; and premium moissanite gemstones under the Forever One brand name. The company also markets and distributes lab grown diamonds and finished jewelry with lab grown diamonds under the Caydia brand. It sells its products at wholesale prices to distributors, manufacturers, retailers, and designers; and to end-consumers at retail prices through charlesandcolvard.com and moissaniteoutlet.com, third-party online marketplaces, drop-ship, and other e-commerce outlets, as well as through Charles & Colvard Signature Showroom and charlesandcolvarddirect.com for wholesale and retail customers. Charles & Colvard, Ltd. was incorporated in 1995 and is headquartered in Morrisville, North Carolina.

CTHR Stock Price History

CTHR Stock News Headlines

Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Charles & Colvard, Ltd. (CTHR)
Q2 2024 Charles & Colvard Ltd Earnings Call
Charles Robinson - Yahoo Sports
Charles & Colvard Ltd CTHR
Charles Schwab Corp SCHW
Charles & Colvard Insiders Placed Bullish Bets Worth US$1.8m
See More Headlines
Receive CTHR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Charles & Colvard, Ltd. and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/04/2021
Today
3/02/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Industry
Jewelry, silverware, & plated ware
Sub-Industry
N/A
Current Symbol
NASDAQ:CTHR
Employees
48
Year Founded
N/A

Profitability

Net Income
$-19,580,000.00
Pretax Margin
-66.69%

Debt

Sales & Book Value

Annual Sales
$29.95 million
Book Value
$1.14 per share

Miscellaneous

Free Float
24,003,000
Market Cap
$10.68 million
Optionable
Not Optionable
Beta
0.93
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report














CTHR Stock Analysis - Frequently Asked Questions

How have CTHR shares performed in 2024?

Charles & Colvard, Ltd.'s stock was trading at $0.4102 at the beginning of 2024. Since then, CTHR stock has decreased by 14.2% and is now trading at $0.3521.
View the best growth stocks for 2024 here
.

Are investors shorting Charles & Colvard, Ltd.?

Charles & Colvard, Ltd. saw a drop in short interest in the month of February. As of February 15th, there was short interest totaling 37,700 shares, a drop of 43.1% from the January 31st total of 66,200 shares. Based on an average daily volume of 139,900 shares, the short-interest ratio is currently 0.3 days. Approximately 0.2% of the shares of the company are sold short.
View Charles & Colvard, Ltd.'s Short Interest
.

When is Charles & Colvard, Ltd.'s next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our CTHR earnings forecast
.

How were Charles & Colvard, Ltd.'s earnings last quarter?

Charles & Colvard, Ltd. (NASDAQ:CTHR) posted its quarterly earnings results on Thursday, November, 4th. The company reported $0.03 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.02 by $0.01. The firm earned $10.28 million during the quarter, compared to analysts' expectations of $9.20 million. Charles & Colvard, Ltd. had a negative net margin of 91.98% and a negative trailing twelve-month return on equity of 57.44%. During the same period last year, the company posted $0.03 earnings per share.

What other stocks do shareholders of Charles & Colvard, Ltd. own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Charles & Colvard, Ltd. investors own include Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Golar LNG Partners (GMLP), Novan (NOVN), Organigram (OGI), Pennsylvania Real Estate Investment Trust (PEI), Bionano Genomics (BNGO), Gran Tierra Energy (GTE), Zosano Pharma (ZSAN) and Aeterna Zentaris (AEZS).

Who are Charles & Colvard, Ltd.'s major shareholders?

Charles & Colvard, Ltd.'s stock is owned by a variety of institutional and retail investors. Top institutional investors include Citadel Advisors LLC (0.32%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Clint J Pete, Don O'connell, Neal I Goldman and Ollin B Sykes.
View institutional ownership trends
.

How do I buy shares of Charles & Colvard, Ltd.?

Shares of CTHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CTHR) was last updated on 3/3/2024 by MarketBeat.com Staff